N-desethyloxybutynin

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameN-desethyloxybutynin
Drug Alias NameNRX-101 (NeuRx Pharmaceuticals)NRX-101 (Neos Therapeutics)N-desethyloxybutynin (Neos Therapeutics)NT-0501NT-0502
ClassificationSmall molecules
Mechanisms of ActionMuscarinic acetylcholine receptor antagonists
TargetsMuscarinic acetylcholine receptor
Therapy Area/IndicationsSialorrhea
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesNeos Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesAytu BioPharma Inc
Inactive CompaniesNeos Therapeutics Inc
Active IndicationsSialorrhea
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A